Literature DB >> 10767986

Production of recombinant human type I procollagen homotrimer in the mammary gland of transgenic mice.

P D Toman1, F Pieper, N Sakai, C Karatzas, E Platenburg, I de Wit, C Samuel, A Dekker, G A Daniels, R A Berg, G J Platenburg.   

Abstract

The large scale production of recombinant collagen for use in biomaterials requires an efficient expression system capable of processing a large (> 400 Kd) multisubunit protein requiring post-translational modifications. To investigate whether the mammary gland of transgenic animals fulfills these requirements, transgenic mice were generated containing the alpha S1-casein mammary gland-specific promoter operatively linked to 37 Kb of the human alpha 1(I) procollagen structural gene and 3' flanking region. The frequency of transgenic lines established was 12%. High levels of soluble triple helical homotrimeric [(alpha 1)3] type I procollagen were detected (up to 8 mg/ml) exclusively in the milk of six out of 9 lines of lactating transgenic mice. The transgene-derived human procollagen chains underwent efficient assembly into a triple helical structure. Although proline or lysine hydroxylation has never been described for any milk protein, procollagen was detected with these post-translational modifications. The procollagen was stable in milk; minimal degradation was observed. These results show that the mammary gland is capable of expressing a large procollagen gene construct, efficiently assembling the individual polypeptide chains into a stable triple helix, and secreting the intact molecule into the milk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10767986     DOI: 10.1023/a:1008959924856

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  90 in total

1.  A high-yield method for the isolation of hydrophobic proteins and peptides from polyacrylamide gels for protein sequencing.

Authors:  R G Feick; J A Shiozawa
Journal:  Anal Biochem       Date:  1990-06       Impact factor: 3.365

2.  Secretion of unprocessed human surfactant protein B in milk of transgenic mice.

Authors:  S Yarus; N M Greenberg; Y Wei; J A Whitsett; T E Weaver; J M Rosen
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

3.  Hydroxyproline stabilizes the triple helix of chick tendon collagen.

Authors:  S Jimenez; M Harsch; J Rosenbloom
Journal:  Biochem Biophys Res Commun       Date:  1973-05-01       Impact factor: 3.575

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Dermal filler materials.

Authors:  M L Elson
Journal:  Dermatol Clin       Date:  1993-04       Impact factor: 3.478

6.  Collagen: an overview.

Authors:  E J Miller; S Gay
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Collagen synthesis and secretion by rat incisor odontoblasts in organ culture.

Authors:  E C Munksgaard; M Rhodes; R Mayne; W T Butler
Journal:  Eur J Biochem       Date:  1978-01-16

8.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

9.  Expression of synthetic cDNA sequences encoding human insulin-like growth factor-1 (IGF-1) in the mammary gland of transgenic rabbits.

Authors:  G Brem; P Hartl; U Besenfelder; E Wolf; N Zinovieva; R Pfaller
Journal:  Gene       Date:  1994-11-18       Impact factor: 3.688

10.  A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast.

Authors:  S Minafra; V Morello; F Glorioso; A M La Fiura; R M Tomasino; S Feo; D McIntosh; D E Woolley
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

View more
  8 in total

1.  Prospects and limitations of the rational engineering of fibrillar collagens.

Authors:  Ireneusz Majsterek; Erin McAdams; Eijiro Adachi; Shirish T Dhume; Andrzej Fertala
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

2.  The creation of transgenic pigs expressing human proteins using BAC-derived, full-length genes and intracytoplasmic sperm injection-mediated gene transfer.

Authors:  Masahito Watanabe; Mayuko Kurome; Hitomi Matsunari; Kazuaki Nakano; Kazuhiro Umeyema; Akira Shiota; Hiromitsu Nakauchi; Hiroshi Nagashima
Journal:  Transgenic Res       Date:  2011-10-25       Impact factor: 2.788

Review 3.  Bioactive polymer scaffold for fabrication of vascularized engineering tissue.

Authors:  Irza Sukmana
Journal:  J Artif Organs       Date:  2012-04-21       Impact factor: 1.731

Review 4.  Collagens as biomaterials.

Authors:  John A M Ramshaw; Yong Y Peng; Veronica Glattauer; Jerome A Werkmeister
Journal:  J Mater Sci Mater Med       Date:  2008-04-01       Impact factor: 3.896

5.  Natural and Genetically Engineered Proteins for Tissue Engineering.

Authors:  Sílvia Gomes; Isabel B Leonor; João F Mano; Rui L Reis; David L Kaplan
Journal:  Prog Polym Sci       Date:  2012-01-01       Impact factor: 29.190

6.  A Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterial.

Authors:  Yong Y Peng; Ayumi Yoshizumi; Stephen J Danon; Veronica Glattauer; Olga Prokopenko; Oleg Mirochnitchenko; Zhuoxin Yu; Masayori Inouye; Jerome A Werkmeister; Barbara Brodsky; John A M Ramshaw
Journal:  Biomaterials       Date:  2010-01-06       Impact factor: 12.479

Review 7.  Sources of Collagen for Biomaterials in Skin Wound Healing.

Authors:  Evan Davison-Kotler; William S Marshall; Elena García-Gareta
Journal:  Bioengineering (Basel)       Date:  2019-06-30

8.  Design and construction of two yeast shuttle vectors containing human procollagen genes expression cassette for expression in yeast.

Authors:  Baharak Abdemami; Mohammad Ali Shokrgozar; Hossein Khanahmad Shahreza; Mehdi Ghavami
Journal:  Avicenna J Med Biotechnol       Date:  2011-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.